SC
BCAB icon

Steven Cohen’s BioAtla BCAB Stock Holding History

Steven Cohen’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,994
Closed -$5.36M – 2234
2022
Q4 		$5.36M Sell
12,994
-2,300
-15% -$954K 0.02% 731
2022
Q3 		$5.89M Buy
+15,294
New +$5.01M 0.02% 664
2021
Q4 		– Sell
-2,572
Closed -$3.79M – 1088
2021
Q3 		$3.79M Buy
+2,572
New +$5.01M 0.02% 714

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Steven Cohen's BCAB Position: Q1 2023 in Review

Steven Cohen sold out of BioAtla (BCAB) in Q1 2023, closing a stake of 12,994 shares — an estimated $5.36M sold.

Steven Cohen first reported a position in BCAB in Q3 2021 and held it in 3 quarters. The position peaked at $5.89M in Q3 2022. 79 funds tracked by Wall St. Rank hold BCAB as of Q1 2023.

  • Steven Cohen reported no remaining BioAtla position as of Q1 2023 after selling out during the quarter.
  • Steven Cohen sold 12,994 BioAtla shares in Q1 2023, an estimated $5.36M.
  • Steven Cohen first reported a position in BioAtla in Q3 2021 and held it in 3 quarters.
  • Steven Cohen's BioAtla position peaked at $5.89M in Q3 2022.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q1 2023.

Based on Point72 Asset Management's 13F filing for Q1 2023, filed 15 May 2023.